Page last updated: 2024-08-26
fpl 55712 and mci 826
fpl 55712 has been researched along with mci 826 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Horiba, M; Nabe, T; Ohata, K; Watanabe-Kohno, S; Yamamura, H | 1 |
Other Studies
1 other study(ies) available for fpl 55712 and mci 826
| Article | Year |
|---|---|
MCI-826 is a potent and selective antagonist of peptide leukotrienes (p-LTs) and has characteristics distinctive from those of FPL 55712.
Topics: Acetylcholine; Animals; Bronchi; Chromones; Guinea Pigs; Humans; Leukotriene Antagonists; Leukotrienes; Muscle Contraction; Muscle, Smooth; Prostaglandin D2; Respiratory Physiological Phenomena; Respiratory System; SRS-A; Thiazoles; Trachea | 1992 |